BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26897960)

  • 1. Toward Curative Fluorescence-Guided Surgery of Pancreatic Cancer.
    Bouvet M; Hoffman RM
    Hepatogastroenterology; 2015 May; 62(139):715-22. PubMed ID: 26897960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
    Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.
    Kaushal S; McElroy MK; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
    J Gastrointest Surg; 2008 Nov; 12(11):1938-50. PubMed ID: 18665430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
    Metildi CA; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2014 Jul; 219(1):132-41. PubMed ID: 24768506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
    Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
    J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
    Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
    J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
    Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
    Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
    Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Metildi CA; Kaushal S; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
    J Surg Oncol; 2014 Apr; 109(5):451-8. PubMed ID: 24249594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer.
    Tran Cao HS; Kaushal S; Metildi CA; Menen RS; Lee C; Snyder CS; Messer K; Pu M; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
    Hepatogastroenterology; 2012 Sep; 59(118):1994-9. PubMed ID: 22369743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation.
    McElroy M; Kaushal S; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
    World J Surg; 2008 Jun; 32(6):1057-66. PubMed ID: 18264829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.
    DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M
    J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.
    Hiroshima Y; Maawy A; Metildi CA; Zhang Y; Uehara F; Miwa S; Yano S; Sato S; Murakami T; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Laparoendosc Adv Surg Tech A; 2014 Apr; 24(4):241-7. PubMed ID: 24494971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models.
    Metildi CA; Kaushal S; Hardamon CR; Snyder CS; Pu M; Messer KS; Talamini MA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2012 Jul; 215(1):126-35; discussion 135-6. PubMed ID: 22632917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors.
    Yazaki P; Lwin T; Minnix M; Li L; Sherman A; Molnar J; Miller A; Frankel P; Chea J; Poku E; Bowles N; Hoffman R; Shively J; Bouvet M
    J Biomed Opt; 2019 Jun; 24(6):1-9. PubMed ID: 31254333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models.
    Park JY; Lee JY; Zhang Y; Hoffman RM; Bouvet M
    Oncotarget; 2016 Apr; 7(14):18262-8. PubMed ID: 26919100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific tumor labeling enhanced by polyethylene glycol linkage of near infrared dyes conjugated to a chimeric anti-carcinoembryonic antigen antibody in a nude mouse model of human pancreatic cancer.
    Maawy AA; Hiroshima Y; Zhang Y; Luiken GA; Hoffman RM; Bouvet M
    J Biomed Opt; 2014; 19(10):101504. PubMed ID: 24887695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.